Literature DB >> 24622440

Genetic analysis of a congenital nephrogenic diabetes insipidus pedigree.

Yunfeng Shen1, Xiaoyang Lai2, Xinlan Xiao3, Jing Li2, Rong Yu2, Hui Gao2, Meiying Zhang2.   

Abstract

BACKGROUND: As an X-linked recessive way, arginine vasopressin receptor 2 (AVPR2) gene mutation resulted in a hereditary disease - congenital nephrogenic diabetes insipidus (CNDI). We found a suspect clinical CNDI pedigree. In order to identify the genetic etiology, we performed the genetic analysis.
METHODS: The clinical features of the proband and his family members were recorded. The laboratory tests and imaging inspections were analyzed. The water deprivation and pituitrin loading test were performed in the proband and his brother. The genomic DNA of all the members of the pedigree was extracted and then PCR amplification on AVPR2 gene was carried out. Sequencing in both directions was performed to identify mutation on AVPR2 gene.
RESULTS: Both the proband and his brother were diagnosed as CNDI, meanwhile the other members of this pedigree were normal. No severe biochemical abnormality was found in the two CNDI patients. Both the patients had moderate urinary retention, severe megaloureter and hydronephrosis, and mild renal insufficiency. Two mutations of AVPR2 gene were discovered in the 3rd exon in the patients, a silent mutation L309L and a nonsense mutation R337X. The AVPR2 gene R337X mutation was co-segregated with CNDI. R337X mutation was not a reported mutation in the mainland of China.
CONCLUSION: The AVPR2 gene R337X mutation was also a genetic etiology of CNDI patients in the mainland of China.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24622440

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  1 in total

1.  A Novel Missense Mutation of Arginine Vasopressin Receptor 2 in a Chinese Family with Congenital Nephrogenic Diabetes Insipidus: X-Chromosome Inactivation in Female CNDI Patients with Heterozygote 814A>G Mutation.

Authors:  Li Zang; Yuping Gong; Yijun Li; Jingtao Dou; Zhaohui Lyu; Xiaoqing Su; Yawei Zhang; Yiming Mu
Journal:  Biomed Res Int       Date:  2022-07-12       Impact factor: 3.246

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.